Xiaobin Xu

Title: The Innovative Contributions of Xiaobin Xu

Introduction

Xiaobin Xu is a prominent inventor based in White Plains, NY (US). He has made significant contributions to the field of therapeutic biomolecules, holding a total of 8 patents. His work focuses on the quantitation and modeling of quality attributes of therapeutic monoclonal antibodies, which has important implications for the pharmaceutical industry.

Latest Patents

Xiaobin Xu's latest patents include groundbreaking methods for predicting in vivo serum concentrations of antibodies with post-translational modifications. These methods allow for the prediction of a subject's exposure to post-translational variants of antibodies, enhancing the understanding of their therapeutic effects. Additionally, he has developed methods for predicting and modulating glycation of proteins, which involve determining rates for de-glycation reactions at various temperatures. This innovation aids in maintaining the glycation percentage of therapeutic biomolecules, ultimately improving their efficacy and shelf-life.

Career Highlights

Throughout his career, Xiaobin Xu has worked with notable companies such as Regeneron Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. His expertise in the field has led to advancements that benefit both researchers and patients alike.

Collaborations

Xiaobin Xu has collaborated with esteemed colleagues, including Haibo Qiu and Yu Huang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Xiaobin Xu's contributions to the field of therapeutic biomolecules are invaluable. His innovative patents and collaborative efforts continue to shape the future of medicine and improve patient outcomes.